InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,554.71
(
0.83%
)
US TECH 100
19,806.26
(
0.84%
)
Dow Jones
39,260.65
(
-0.12%
)
Brent Oil
87.15
(
-0.21%
)
Bitcoin
56,433.12
(
-0.96%
)
Post# of 252491
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

tony111

Send PM Follow Ignore
Followers 10
Posts 1064
Boards Moderated 0
Alias Born 11/24/2007

tony111

Re: DonShimoda post# 86092

Tuesday, 11/10/2009 6:04:52 PM

Tuesday, November 10, 2009 6:04:52 PM

Post# of 252491
Don,

534 was designed to be a pan BCR-ABL inhibitor rather than T315I specific. However, the management is looking for third-line now and other solid tumor indications. Maybe when the drug is approved they will run a head to head with Tasigna and Sprycel.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up